Warning: session_start() [function.session-start]: Cannot send session cookie - headers already sent by (output started at /home/content/95/6355395/html/index.php:2) in /home/content/95/6355395/html/index.php on line 3

Warning: session_start() [function.session-start]: Cannot send session cache limiter - headers already sent (output started at /home/content/95/6355395/html/index.php:2) in /home/content/95/6355395/html/index.php on line 3
Board of Directors
Home  »  AboutLegacy  »  Board of Directors
Font Size
Board of Directors

Edward J. Dineen, Chairman of the Board
TPC Group

Ed Dineen is the former CEO and President of Siluria Technologies. He is currently the Chairman, President and Chief Executive Officer of TPC Group, a leading producer of value-added products derived from niche petrochemical raw materials. Mr. Dineen was formerly President and Chief Executive Officer of LS9, which develops biotechnology-based fuels and chemicals. Prior to joining LS9, Mr. Dineen served as Cheif Operating Officer of LyondellBasell, one of the world’s largest polymers, petrochemical and fuels companies where he was responsible for manufacturing, environmental, health and safety, business management and sales, research and development, supply and procurement and business finance. During his 32 year career at LyondellBasell Industries and its predecessor companies, he was directly involved in growing many of the fuels and chemicals businesses into global market leading positions. Mr. Dineen was formerly a member of the Board of Directors of LS9 and Spartech, a U.S.-based plastics company. A native of New York City, Mr. Dineen received his bachelor's and master's degrees in chemical engineering from the Cooper Union and Princeton University, respectively. He also holds a Master of Science in management from Drexel University.

Raaid K. Alireza
National Petrochemical Industrial Company, Xenel Group

Raaid Alireza heads Xenel’s Investment Center for the last seven years where he is responsible for investments and corporate finance activities for Xenel Industrial Group. Raaid has been instrumental in the development of a number of NatPet downstream petrochemical projects in Saudi Arabia; a JV with Low & Bonar of the UK producing nonwoven geotextiles and a JV with A. Schulman of the U.S. which will produce polypropylene compounds. Previously, Raaid worked for Deutsche Bank in London and Dubai for four years where he started in Equity Derivatives then moved to the Middle East corporate finance team focusing on the Saudi market. He worked on a number of IPOs, private placements, mergers and acquisitions, and various forms of financings. Raaid serves on the board of directors of AECOM Arabia, a JV with global leading engineering firm AECOM. He also serves on the Audit Committee of NatPet as well as the Chairman of Hidada’s Executive Committee. Raaid received his Bachelors of Science degree in Industrial Engineering & Operations Research as well as his Masters of Science in Civil & Environmental Engineering from the University of California at Berkeley. At U.C. Berkeley, he currently serves on the IEOR Advisory Board and previously served on the College of Engineering Advisory Board.

Clinton Bybee
ARCH Venture Partners

Clinton Bybee is a founding director of Siluria Technologies. Mr Bybee is a co-founder and Managing Director of ARCH Venture Partners. He has helped organize and develop numerous companies including MicroOptical Devices (acquired by EMCORE), Impinj, Cambrios Technologies, Siluria Technologies, Innovalight (acquired by DuPont), Intelligent Reasoning Systems (acquired by Photon Dynamics), and CoolEdge Lighting.  Mr. Bybee earned an M.B.A. from the University of Chicago and a B.S. in Petroleum Engineering from Texas A&M University, and held a number of operating roles at Amoco Corporation.


Mark Noetzel
Chairman of Board, Aspen Aerogels, Inc.

Mark Noetzel joined the Siluria Board of Directors in October, 2011. He combines experience with both large, publicly-traded firms and high technology start-ups. Currently, he is Chairman of the Board of Aspen Aerogels, Inc. (NYSE: ASPN), a leading energy technology company which was publicly listed in June, 2014. Mr. Noetzel was also Chairman of the Board of Directors of Axiall Corporation (NYSE:AXLL), prior to its acquisition by Westlake Chemical Corp. in 2016. From 2007 to 2009, he was Chief Executive Officer and President of Cilion, Inc., a venture-backed biofuels company. Prior to joining Cilion, Mr. Noetzel was with BP and Amoco for 26 years, leading multi-billion dollar businesses in the fuels and chemical industry in the US, Europe and Asia. In 2003, he was appointed Group Vice President with responsibility for BP’s $65 billion revenue retail operations and fuels transport and wholesaling in the US, Europe and Asia. Mr. Noetzel directed major parts of BP’s portfolio for a decade, having been named a Group Vice President in 1996. Previously, he was Group Vice President with responsibility for BP’s Fuels Operations in China, Africa and Australasia, and the aviation businesses, and prior to that in BP and Amoco’s chemical businesses across a broad range of chemical manufacturing and marketing activities. Mr. Noetzel was instrumental in the growth of BP’s chemical business in East Asia where he lived for almost six years. Mark Noetzel holds a BA in international relations/political science from Yale University in 1979 and an MBA from the Wharton School of the University of Pennsylvania.


Dr. Leighton Read
Alloy Ventures 

Leighton Read was the founding Chairman of Siluria representing Alloy Ventures where he was a Managing Member in four funds and now serves as a Venture Partner. Before joining Alloy, Leighton spent 14 years as a biotechnology entrepreneur and investor. He co-founded Affymax NV, under the direction of Dr. Alejandro Zaffaroni, setting the stage for two successful spin-outs: Affymetrix and Maxygen. He founded Aviron, a biotechnology company best known as the developer of FluMist™, the intranasal influenza vaccine, where he served as Chairman and CEO until 1999 and Director until its acquisition by MedImmune in 2002. While at Alloy, he served as the first CEO of Avidia, a spin-out of Maxygen later acquired by Amgen. He received a B.S. from Rice University in Psychology and Biology, an MD from the University of Texas Health Science Center at San Antonio and completed internal medicine training at Duke and the Peter Bent Brigham Hospital in Boston where he held appointments at the Harvard Medical School and School of Public Health. He is also a director of Alexza Pharmaceuticals, Cambrios Technologies, Genomatica and Seriosity. He serves on the non-profit boards of BeneTech, BioVentures for Global Health, the UC Berkeley Foundation and School of Public Health, the Institute for Systems Biology, and the Santa Fe Institute. His awards include the EY Northern California Entrepreneur of the Year and several as co-inventor of the technology underlying the Affymetrix GeneChip™. 



Dr. Johanna Schmidtke
Saudi Aramco Energy Ventures

Johanna Schmidtke is an Investment Director with Saudi Aramco Energy Ventures, the corporate venturing arm of Aramco. In this role, she is responsible for leading technology investments with a strategic fit to Aramco's business needs in the areas of: upstream oil & gas; downstream oil & gas and value-added products; renewable energy; energy efficiency and water. Through her work in corporate ventures capital and corporate development, as well as a background in technical research, she offers of a unique combination of technical insight and commercial aptitude in the industrial space. Prior to her current position, Johanna worked with the Advisory practice at PricewaterhouseCoopers, Corporate Development & Strategy at First Solar Inc., and the consulting practice at Lux Research. She serves as a board director at ConXtech and as a board observer at Novomer. She holds a Ph.D. in Physics from the University of Cambridge as a Gates Scholar and a B.S. from the University of Arizona. 

Robert Trout
CEO, Siluria Technologies

Robert Trout joined Siluria in September of 2016 as Chief Executive Officer.  He is a seasoned energy industry executive with thirty years of experience and a track record of leading multiple organizations to year-on–year performance improvements.  Mr. Trout has held numerous global roles in executive management, strategic planning, commercial and business development, strategic projects, operations, and corporate governance.  Prior to joining Siluria, Mr. Trout was President of Criterion Catalysts & Technologies, an independent technology company owned by Royal Dutch Shell.  Prior to this role, he held a number of senior leadership positions within the Shell Group including President of CRI Catalyst Company, and Vice President of Strategic Projects for the Projects &Technology and Chemicals divisions.  He has served as Chairman of the Board of Zeolyst International as well as a member of numerous boards of directors of affiliated companies of the Shell Group.  Mr. Trout holds a BS in Chemical Engineering from Oregon State University as well as completion of The Marketing Management Program at Columbia University and The Management MBA Program at Rice University.